Literature DB >> 24789515

Long-term treatment outcome of two patients with pyridoxine-dependent epilepsy caused by ALDH7A1 mutations: normal neurocognitive outcome.

Enas Nasr1, Eva Mamak2, Anette Feigenbaum3, Elizabeth J Donner4, Saadet Mercimek-Mahmutoglu5.   

Abstract

Pyridoxine-dependent epilepsy is an autosomal recessively inherited disorder of lysine catabolism caused by mutations in the ALDH7A1 gene. We report 2 patients with normal neurocognitive outcome (full-scale IQ of 108 and 74) and their more than 10 years' treatment outcome on pyridoxine monotherapy. Both patients had specific borderline impairments in visual processing speed. More long-term treatment outcome reports will increase our knowledge about the natural history of the disease.
© The Author(s) 2014.

Entities:  

Keywords:  ALDH7A1; alpha-amino adipic acid semialdehyde; long-term treatment; neurodevelopment; pyridoxine; pyridoxine-dependent epilepsy

Mesh:

Substances:

Year:  2014        PMID: 24789515     DOI: 10.1177/0883073814531331

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.

Authors:  Amal Al Teneiji; Theodora U J Bruun; Dawn Cordeiro; Jaina Patel; Michal Inbar-Feigenberg; Shelly Weiss; Eduard Struys; Saadet Mercimek-Mahmutoglu
Journal:  Metab Brain Dis       Date:  2016-11-23       Impact factor: 3.584

2.  Structural and biochemical consequences of pyridoxine-dependent epilepsy mutations that target the aldehyde binding site of aldehyde dehydrogenase ALDH7A1.

Authors:  Adrian R Laciak; David A Korasick; Jesse W Wyatt; Kent S Gates; John J Tanner
Journal:  FEBS J       Date:  2019-07-25       Impact factor: 5.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.